NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM3993203 Query DataSets for GSM3993203
Status Public on Aug 01, 2019
Title PilocyticAstrocytoma_14_tumor
Sample type RNA
 
Source name Pilocytic astrocytoma, tumor, patient14
Organism Homo sapiens
Characteristics tissue: Tumor
gender: Male
age at diagnosis: 16y
chemotherapy: No
neurofibromatosis type 1 (nf1): No
follow up (month): 19
kiaaa159-braf fusion: ND
relapse: Yes
vital status: Death
Extracted molecule total RNA
Extraction protocol Fresh surgical tissues were immediately snap-frozen in liquid nitrogen, stored at −80 °C and microdissected prior to RNA extraction and only specimen with at least 80% of tumor cells were included in the study. Total cellular RNA was extracted using TRIzol LS Reagent (Invitrogen, Carlsbad, CA, USA) according to the anufacturer’s instructions. The RNA was reverse transcribed to single-stranded cDNA using the High Capacity Kit (Applied Biosystems, Foster City, CA, USA).
Label Cy3
Label protocol The microRNA library was constructed using 100 ng of total RNA and investigated with the Agilent Human microRNA Microarray Kit (v3)” (G4470C, Agilent Technologies, Santa Clara, CA, USA) to determine the expression profile of microRNAs according to manufacturer’s instructions. This array contains 866 human and 89 human viral microRNA sequences. Each miRNA species is printed 20 times with replicate probes on the array.
 
Hybridization protocol The labeled RNA was purified (MicroBioSpin 6, Bio-Rad, 732-6221), hybridized (overnight for 20 hours at 55°C and 20 rpm) and washed (Agilent, 5188-5327) before scanning.
Scan protocol Microarray slides were scanned at 535 nm with 5 μm/pixel resolution using a DNA Microarray Scanner with SureScan High-Resolution Technology (Agilent Technologies) and the fluorescent intensities were determined by the Feature Extraction Software Version 11.5 (Agilent Technologies), to obtain Processed Signals (resulting from all intra-array pre-processing, including background corrections) corresponding to the transcript levels.
Data processing The spot images were processed with Feature Extraction Software v10.7.3.1 (Agilent Technologies). Each miRNA microarray was analyzed with respect to signal intensity, background signal, as well as internal control blade and spike in controls. A box-plot was generated in order to determine the distribution of signals from each spot on each microarray as well as sample integrity and quality.
An empirical Bayesian approach was used to determine differential expression and the false discovery rate (FDR) was used to control the false-positive rate. Normalization was performed by the 75% quartile method.
 
Submission date Jul 31, 2019
Last update date Aug 01, 2019
Contact name Carlos Alberto Scrideli
E-mail(s) scrideli@fmrp.usp.br
Phone 55 16 39636630
Organization name Ribeirao Preto Medicine School - University of Sao Paulo
Department Pediatrics
Street address Avenida Bandeirantes 3900
City Ribeirão Preto
State/province São Paulo
ZIP/Postal code 14048900
Country Brazil
 
Platform ID GPL20906
Series (1)
GSE135189 MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter

Data table header descriptions
ID_REF
VALUE processed Cy3 signal intensity (Agilent gProcessedSignal)

Data table
ID_REF VALUE
1 1.483996e+003
2 -1.947403e+000
3 3.292025e+004
4 -5.944359e+000
5 -3.384558e+000
6 -4.168046e+000
7 -5.765411e+000
8 1.907309e+000
9 -1.175817e-001
10 2.504381e+000
11 -8.615311e-001
12 -3.268321e-001
13 -4.112963e-001
14 2.773697e+000
15 -5.484957e+000
16 9.209652e-002
17 -3.446525e+000
18 -5.682976e+000
19 4.827019e+000
20 2.313303e+000

Total number of rows: 15739

Table truncated, full table size 301 Kbytes.




Supplementary file Size Download File type/resource
GSM3993203_AP_14.txt.gz 2.3 Mb (ftp)(http) TXT
Processed data included within Sample table
Processed data provided as supplementary file
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap